New research suggests that individuals who discontinue popular GLP-1 drugs like Wegovy and Mounjaro can put back on shed pounds far faster than those who end conventional diet and exercise plans.
Published data in a prominent medical journal shows that while overweight individuals can lose substantial amounts of their total mass while on the medication, the weight returns at an estimated rate of nearly a kilo each month after stopping.
"Individuals buying these drugs should be aware of the potential of quick weight regain when the therapy concludes," warns expert Dr. Susan Jebb.
This pace of recovery suggests a return to pre-treatment weight within about a year and a half.
Analyzing Treatments
The analysis, which looked at dozens of trials involving thousands of participants, contrasted the effects of these new drugs with older methods.
Researchers point out that individuals who lose weight through lifestyle changes alone usually experience a more gradual weight regain—around 100 grams monthly—after stopping.
Understanding the Rapid Regain
Doctors suggest the way of the drugs accounts for the accelerated rebound.
GLP-1 drugs imitate a body's own chemical called GLP-1, which controls appetite.
"Sustained high doses of the hormone levels far above than normal could lead to the system to generate a reduced amount of its own natural GLP-1, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication results in appetite is uncontrolled, making binge eating much more probable."
An Ongoing Issue?
Health authorities recommend the injections for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.
Professionals contend that, considering the likelihood of weight regain, the therapy is often life-long.
This perspective is echoed by pharmaceutical companies, who state that the findings "underscore the long-term character of obesity," akin to managing conditions like hypertension.
User Experiences
Users who have discontinued the jabs report a intense resurgence of cravings.
"It felt as if something that goes on and you become extremely hungry," described one woman.
The struggle is compounded if patients have not established permanent lifestyle or habit changes during treatment.
Significant Use
Recent estimates suggest that millions of people in the UK have tried weight-loss jabs in the past year, with interest remaining high.
- Use is more common among women than men.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion obtain the medications through private healthcare rather than the NHS.
In conclusion, researchers caution that while the jabs are powerful agents for shedding pounds, they are not a magic solution and lasting health benefits hinges on combined lifestyle management.
